严重孤立性胸部或腹部创伤失血性休克患者中复苏性主动脉内球囊阻断术(REBOA)的结局
该回顾性队列分析利用美国外科医师学会创伤质量改进项目数据库(2017—2023年),纳入因严重孤立性胸部或腹部创伤接受REBOA置入的成人患者,按REBOA分区、损伤类型和创伤中心级别分层,主要终点为急诊科死亡和24小时死亡。结果显示,REBOA与死亡率升高显著相关(aOR 15.456,95%CI 3.340-71.516,p<0.001),并与4小时输血需求(β=3177.081,95%CI 59.315-6294.848,p=0.046)和24小时输血需求(β=2750.609,95%CI 704.078-4797.141,p=0.008)增加相关,钝性和穿透性损伤中均如此。在II级创伤中心接受REBOA的患者24小时死亡 odds 更高。止血时间和并发症发生率无显著差异。作者结论认为,REBOA在这些患者中应逐例谨慎考虑。
要点
- 在严重孤立性胸部或腹部创伤失血性休克成人中,REBOA使用与死亡率升高显著相关(aOR 15.456,95%CI 3.340-71.516,p<0.001)。
- REBOA使用与4小时输血需求(β=3177.081,95%CI 59.315-6294.848,p=0.046)和24小时输血需求(β=2750.609,95%CI 704.078-4797.141,p=0.008)增加相关。
- 在II级创伤中心接受REBOA的患者24小时死亡 odds 更高。
- 止血时间和并发症发生率在REBOA使用与否之间无显著差异。
- 作者认为,对严重创伤患者使用REBOA应逐例谨慎考虑。
适用人群与场景
- 成人严重孤立性胸部或腹部创伤、处于失血性休克、接受REBOA置入的患者,数据来自ACS-TQIP-PUF数据库2017—2023年。
研究设计与关键结果
- 研究类型为回顾性队列分析,使用美国外科医师学会创伤质量改进项目参与者使用文件(ACS-TQIP-PUF)数据库2017—2023年数据,纳入严重孤立性胸部或腹部创伤并接受REBOA置入的成人患者,按REBOA分区、损伤类型和创伤中心级别分层。
- 主要终点:REBOA与死亡率升高显著相关(aOR 15.456,95%CI 3.340-71.516,p<0.001)。
- 次要终点:REBOA与4小时输血需求增加相关(β=3177.081,95%CI 59.315-6294.848,p=0.046),与24小时输血需求增加相关(β=2750.609,95%CI 704.078-4797.141,p=0.008),钝性和穿透性损伤中均如此。
- 在II级创伤中心接受REBOA的患者24小时死亡 odds 更高。
- 止血时间和并发症发生率无显著差异。
证据类型、等级与局限
- 证据类型:回顾性队列分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对严重孤立性胸部或腹部创伤失血性休克成人患者使用REBOA应逐例谨慎考虑。
- 原文未据此给出其他推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There is conflicting literature regarding mortality outcomes associated with REBOA usage in patients with severe thoracic or abdominal trauma. Our study aims to assess the benefits and negative implications of REBOA use in adult trauma patients in hemorrhagic shock with severe thoracic or abdominal injuries.
METHODS: This retrospective cohort analysis utilized the American College of Surgeons Trauma Quality Improvement Program Participant Use File (ACS-TQIP-PUF) database from 2017 to 2023 to evaluate adult patients with severe isolated thoracic or abdominal trauma undergoing REBOA placement. Patients were stratified by REBOA zone, type of injury, and trauma center level. Primary outcomes included Emergency Department (ED) and 24-h mortality. Secondary outcomes included time to hemorrhage control, transfusion volumes, and complications.
RESULTS: In severely injured adult trauma patients with thoracic or abdominal injuries, REBOA was significantly associated with increased mortality (aOR: 15.456, 95 % CI: 3.340-71.516, p < 0.001), 4-h transfusion requirements (β = 3177.081, 95 % CI: 59.315-6294.848, p = 0.046), and 24-h transfusion requirements (β = 2750.609, 95 % CI: 704.078-4797.141, p = 0.008) in both blunt and penetrating injuries. Patients who underwent REBOA at level II trauma centers had greater odds of 24-h mortality. No significant differences were observed in time to hemorrhage control or complication rates.
CONCLUSION: REBOA use in adult trauma patients with severe thoracic or abdominal trauma consistently led to increased mortality and blood transfusion requirements even when outcomes were stratified by REBOA zone placement and trauma center level. REBOA use should be cautiously considered on a case-by-case basis in severely injured patients.
参考来源
- Kumar S, Lee P, Hus A, et al. Outcomes of resuscitative endovascular balloon occlusion of the aorta (REBOA) in severely injured adult trauma patients with isolated thoracic or abdominal trauma in Hemorrhagic shock. Am J Emerg Med. 2025. PMID: 40925055. doi:10.1016/j.ajem.2025.08.068
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。